METHYL 4-BROMO-1-METHYL-1H-INDAZOLE-3-CARBOXYLATE, 95.0%, 1g

5-bromo-4-cloro-3-indossil-α-D-glucopiranoside, 500 mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid, 95.0%, 250mg

N-(2-aminophenyl)-4-methylbenzenesulfonamide, 95+%, 250mg

(3-Bromo-4-chloro-phenyl)-acetic acid, 95.0%, 1g

2-Fluoro-3-methyl-5-phenylpyridine, 97%, 500mg

Polyethylene Glycol Monomethyl Ether 4000500g

Hexaethylene Glycol>98.0%(GC)25g

(2E)-1-(1,3-benzodioxol-5-yl)-3-(dimethylamino)prop-2-en-1-one, 5g

(2R,3R,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98%, 5g

N,N-Dimethylsulfamide>98.0%(N)1g

3-Naphthalen-2-yl-3-oxopropionic acid ethyl ester, 1g

4-(thiophen-2-yl)-2,3-dihydro-1H-1,5-benzodiazepine, 95.0%, 2g